Antisense compounds, compositions and methods are provided for modulating
the expression of polo-like kinase. The compositions comprise antisense
compounds, particularly antisense oligonucleotides, targeted to nucleic
acids encoding polo-like kinase. Methods of using these compounds for
modulation of polo-like kinase expression and for treatment of diseases
associated with expression of polo-like kinase are provided.
